Back to Search
Start Over
Using Automated Live Cell Imaging to Reveal Early Changes during Human Motor Neuron Degeneration.
- Source :
-
ENeuro [eNeuro] 2018 Jun 29; Vol. 5 (3). Date of Electronic Publication: 2018 Jun 29 (Print Publication: 2018). - Publication Year :
- 2018
-
Abstract
- Human neurons expressing mutations associated with neurodegenerative disease are becoming more widely available. Hence, developing assays capable of accurately detecting changes that occur early in the disease process and identifying therapeutics able to slow these changes should become ever more important. Using automated live-cell imaging, we studied human motor neurons in the process of dying following neurotrophic factor withdrawal. We tracked different neuronal features, including cell body size, neurite length, and number of nodes. In particular, measuring the number of nodes in individual neurons proved to be an accurate predictor of relative health. Importantly, intermediate phenotypes were defined and could be used to distinguish between agents that could fully restore neurons and neurites and those only capable of maintaining neuronal cell bodies. Application of live-cell imaging to disease modeling has the potential to uncover new classes of therapeutic molecules that intervene early in disease progression.
- Subjects :
- Benzazepines administration & dosage
Cell Death
Cells, Cultured
Embryonic Stem Cells drug effects
Embryonic Stem Cells pathology
Embryonic Stem Cells physiology
Humans
Indoles administration & dosage
Motor Neurons drug effects
Neurites pathology
Neurites physiology
Pattern Recognition, Automated
Image Processing, Computer-Assisted methods
Motor Neurons pathology
Motor Neurons physiology
Neurodegenerative Diseases pathology
Neurodegenerative Diseases physiopathology
Subjects
Details
- Language :
- English
- ISSN :
- 2373-2822
- Volume :
- 5
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- ENeuro
- Publication Type :
- Academic Journal
- Accession number :
- 29971247
- Full Text :
- https://doi.org/10.1523/ENEURO.0001-18.2018